Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaToward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinomaEag1 channels as potential early-stage biomarkers of hepatocellular carcinomaNon-invasive imaging of Toll-like receptor 5 expression using (131)I-labeled mAb in the mice bearing H22 tumorsiTRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesisEffects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical modelAnnexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer.Application of Real-Time 3D Navigation System in CT-Guided Percutaneous Interventional Procedures: A Feasibility Study.The status of transarterial chemoembolization treatment in the era of precision oncology.Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma.Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.β-ionone modulates the expression of miRNAs and genes involved in the metastatic phenotype of microdissected persistent preneoplastic lesions in rats submitted to hepatocarcinogenesis.
P2860
Q26743361-B7641FC3-CD55-4285-8773-0E0A0D7AA849Q26999411-E43C536D-A1FA-4743-97F6-276DC13974D2Q28069313-991DF3B6-AF4B-40BC-B421-0FBCDE302C40Q33727715-2086D836-C053-4E39-9CEF-E18D2DE28826Q33870833-1A40B3F6-747E-4FD6-99E8-11F691F50B24Q35745018-101FD966-92E5-47D8-A619-9E7BC3D6C9F1Q35752063-66882BDA-C2BC-4549-9AEF-5B9863A96023Q35804238-D484FF5E-0FA0-44EA-9F0D-D7042E492916Q36288548-DCAF1CA4-1F22-487E-9A99-14B4C0012BB0Q36815018-B2400F1E-CC01-487A-984F-DC7F3372536CQ37723978-DD612528-2840-4357-BF34-93EE8D4FC92CQ38441297-9C5C5BEB-E18C-44AE-A55C-18D309DF789CQ38883226-EFB34F37-634A-4467-83D4-5FC4AB6BA813Q40836505-EA59E4FA-5193-48E5-8CE1-9E5AED4D296DQ41530973-10F57CE3-BF2A-4B28-A2B3-265A078DFE90Q42844232-C46BBA4F-438A-4AA9-AC74-CD513662EAF9Q48227182-9F2E44CE-5F08-475C-B313-78D61AC6E78BQ49491370-FB4D2407-DA0D-4987-B96B-91C99DEF4F53Q50999427-EFE9AD0F-910F-4474-AF24-08DBE9E304E1Q52725161-45B8AC38-D7A5-4D3B-A9D2-A56FD9811DEAQ53126300-95776EDD-AB89-4405-9A9F-3DDD977C7880
P2860
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biomarkers for hepatocellular ...... osis, and personalized therapy
@ast
Biomarkers for hepatocellular ...... osis, and personalized therapy
@en
Biomarkers for hepatocellular ...... osis, and personalized therapy
@nl
type
label
Biomarkers for hepatocellular ...... osis, and personalized therapy
@ast
Biomarkers for hepatocellular ...... osis, and personalized therapy
@en
Biomarkers for hepatocellular ...... osis, and personalized therapy
@nl
prefLabel
Biomarkers for hepatocellular ...... osis, and personalized therapy
@ast
Biomarkers for hepatocellular ...... osis, and personalized therapy
@en
Biomarkers for hepatocellular ...... osis, and personalized therapy
@nl
P2093
P2860
P356
P1433
P1476
Biomarkers for hepatocellular ...... osis, and personalized therapy
@en
P2093
P2860
P2888
P356
10.1186/2050-7771-1-10
P577
2013-02-05T00:00:00Z
P5875
P6179
1041087563